Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial-Reference-Cited by-同舟云学术

Effects of an extended flexible regimen of an oral contraceptive pill containing 20 μg ethinylestradiol and 3 mg drospirenone on menstrual-related symptoms: a randomised controlled trial

Published:2016-09-29 Issue:1 Volume:22 Page:11-16
ISSN:1362-5187
Container-title:The European Journal of Contraception & Reproductive Health Care
language:en
Short-container-title:The European Journal of Contraception & Reproductive Health Care

Author:

Machado Rogério Bonassi¹,Pompei Luciano Melo²,Badalotti Mariangela³,Ferriani Rui⁴,Cruz Achilles M.⁵,Nahas Eliana⁶,Maia Hugo⁷

Affiliation:

1. Department of Gynaecology and Obstetrics, Jundiaí School of Medicine, Jundiaí, Brazil;

2. Department of Gynaecology and Obstetrics, ABC School of Medicine, Santo André, Brazil;

3. Department of Gynaecology and Obstetrics, PUC-RS, Porto Alegre, Brazil;

4. Department of Gynaecology and Obstetrics, University of São Paulo (FMRP-USP), Ribeirão Preto, Brazil;

5. Department of Clinical Research, Libbs Farmacêutica Ltda, São Paulo, Brazil;

6. Department of Gynaecology and Obstetrics, Botucatu School of Medicine (FMB-UNESP), UNESP – Sao Paulo State University, Botucatu, Brazil;

7. Centre for Research and Assistance in Human Reproduction, Federal University of Bahia, Salvador, Brazil

Funder

LIBBS FARMACEUTICA LTDA - BRAZIL

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Obstetrics and Gynaecology,Reproductive Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13625187.2016.1239077

Reference20 articles.

1. Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration

2. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms

3. A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 μg on premenstrual symptoms

4. Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric Disorder

5. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Premenstrual disorders: Premenstrual syndrome and premenstrual dysphoric disorder;Journal of Obstetrics and Gynaecology Research;2022-11

2. Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice;Clinical Drug Investigation;2020-09-27

Bleeding Pattern and Management of Unexpected Bleeding/Spotting with an Extended Regimen of a Combination of Ethinylestradiol 20 mcg and Drospirenone 3 mg

;International Journal of Women's Health;2020-03

4. Evaluation of the efficacy, safety, and clinically recommended dose of dienogest in the treatment of primary dysmenorrhea: a randomized, double-blind, multicenter, placebo-controlled study;Fertility and Sterility;2020-01

5. Clinical use of oral contraceptives;Journal of the Korean Medical Association;2017